Close Menu

Parkinson's disease

In Science this week: additional variants linked to development of primary lymphedema, and more.

The partners will leverage MedGenome's database of genetic variants in South Asians to identify and analyze genes and variants associated with Parkinson's disease.

In Nature this week: increased epigenetic upregulation of TET2 in Parkinson's disease, and more.

Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.

In Nature this week: combining genome-wide association and transcriptome study data homes in on cells involved in brain disorders, and more.

Researchers combined genome-wide association and transcriptome study data to uncover cell types affected by complex brain disorders, including Parkinson's disease.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

The Smell Test

A woman's ability to smell differences between people with and without Parkinson's disease could someday lead to a tool to detect the condition early, according to NPR.

In Science this week: phase I study of CRISPR-based engineering of T cells for cancer patients, call for sewage-based global antimicrobial resistance surveillance system, and more.

Cellectricon is researching the spread of neurodegenerative disease-associated peptides that characterize Alzheimer's disease and Parkinson's disease.

Pages

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.